A 63-year-old with AF and HFrEF (EF 30%) asks about rhythm control. Which statement aligns with 2023 AF guidance?...

Question

A 63-year-old with AF and HFrEF (EF 30%) asks about rhythm control. Which statement aligns with 2023 AF guidance?

Accepted Answer

Ablation can be considered early to improve outcomes in select HFrEF patients

Answer

Catheter ablation is contraindicated in HFrEF

Answer

Class Ic drugs are first-line

Answer

Diltiazem is preferred for long-term rate control in HFrEF

Answer

Warfarin is preferred over DOACs for all

"us-abim MCQ (SBA): AF Rhythm Control in HFrEF